Recent findings by Oliva et al. [96] demonstrated that only 10% of endometrial stromal tumors tested positive for CD10, while Agoff et al. [97] and McCluggage et al. [98] reported the absence of CD10 in four out of four and four out of six high-grade ESS cases, respectively. The gene discussed is MME; the disease is endometrioid stromal sarcoma.